Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1995-06-27
1997-09-16
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514103, 514108, A61K 3166
Patent
active
056681208
ABSTRACT:
The present invention relates to methods of inhibiting alveolar bone resorption or the undesirable movement of teeth of a human or other animal comprising:
REFERENCES:
patent: 4153060 (1979-05-01), Korostoff et al.
patent: 4979938 (1990-12-01), Stephen et al.
patent: 5270365 (1993-12-01), Gertz et al.
patent: 5283057 (1994-02-01), Shinoda
Singh, P. and Maibach, H.I. "Iontophoresis in Drug Delivery: Basic Principles and Applications", Critical Reviews in Therapeutic Drug Carrier Systems, vol. 11 (1994), pp. 161-213.
Kasting, G. B., E. W. Merritt and J. C. Keister, "An In Vitro Method for Studying the Iontophoretic Enhancement of Drug Transport Through Skin", Journal of Membrane Science, vol. 35 (1988), pp. 137-159.
Slough, C. L., M. J. Spinelli and G. B. Kasting, "Transdermal Delivery of Etidronate (EHDP) in the Pig Via Iontophroesis", Journal of Membrane Science, vol. 35 (1988), pp. 161-165.
Horiuchi Hiroshi
Shinoda Hisashi
Clark Karen F.
Criares Theodore J.
Suter David L.
The Procter & Gamble & Company
Zea Betty J.
LandOfFree
Iontophoretic delivery of bisphosphonates to the alveolar bone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iontophoretic delivery of bisphosphonates to the alveolar bone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iontophoretic delivery of bisphosphonates to the alveolar bone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218308